ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
2,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
3,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
3,2,Post procedural haematoma,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
3,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
4,1,Haematoma muscle,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
4,2,Hyporeflexia,Abnormal reflexes,Neurological disorders NEC,Nerv,N
4,3,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
5,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
5,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
5,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
6,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
6,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
7,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
7,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
8,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
9,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
10,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
10,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
11,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
11,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
12,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
13,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
13,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
13,3,Pericardial haemorrhage,Pericardial disorders NEC,Pericardial disorders,Card,Y
14,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
14,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
14,3,Headache,Headaches NEC,Headaches,Nerv,N
14,4,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
14,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
14,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
14,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
15,1,Procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
16,1,Post procedural haematoma,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
17,1,Post procedural haematoma,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
18,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
19,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
19,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
19,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
19,4,Post procedural haematoma,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
20,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
20,2,Post procedural haematoma,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
21,1,Procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
22,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
22,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
23,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
24,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
24,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
25,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
25,2,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
26,1,Post procedural haematoma,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
27,1,Small intestinal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
28,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
29,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
30,1,Sciatic nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
31,1,Peroneal nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
31,2,Sciatic nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
32,1,Post procedural haematoma,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
33,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
33,2,Headache,Headaches NEC,Headaches,Nerv,N
33,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
33,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
34,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
35,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
35,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
36,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
37,1,Post procedural haematoma,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
38,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
38,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
39,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
39,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
40,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
41,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
41,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
42,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
42,2,Pelvic abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
42,3,Post procedural haematoma,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
43,1,Haemarthrosis,Arthropathies NEC,Joint disorders,Musc,N
44,1,Pelvic abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
45,1,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,Y
46,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
46,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
47,1,Duodenitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
47,2,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
47,3,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
47,4,Hiatus hernia,Diaphragmatic hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
47,5,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
48,1,Headache,Headaches NEC,Headaches,Nerv,N
48,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
48,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
48,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
49,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
50,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
50,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
51,1,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
51,2,Sciatic nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
52,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
53,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
53,2,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
54,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
54,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
55,1,Retroperitoneal haematoma,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
56,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
56,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
57,1,Osteoporotic fracture,Fractures NEC,Fractures,Musc,N
58,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
59,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
59,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
59,3,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
60,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
60,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
61,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
62,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
63,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
64,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
65,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
66,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
67,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
67,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
68,1,Injection site haematoma,Injection site reactions,Administration site reactions,Genrl,N
69,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
69,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
69,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
70,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
71,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
72,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
73,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
73,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
74,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
74,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
75,1,Injection site haematoma,Injection site reactions,Administration site reactions,Genrl,N
75,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
76,1,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
77,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
78,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
79,1,Post procedural haematoma,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
80,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
81,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
82,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
82,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
82,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
83,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
84,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
84,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
84,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
84,4,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
85,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
86,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
87,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
88,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
88,2,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
89,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
89,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
89,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
90,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
90,2,Rib fracture,Thoracic cage fractures and dislocations,Bone and joint injuries,Inj&P,N
91,1,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
92,1,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
92,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
93,1,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
94,1,Cerebral haematoma,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
94,2,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
95,1,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
96,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
97,1,Aortic valve stenosis,Aortic valvular disorders,Cardiac valve disorders,Card,N
97,2,Atrial septal defect,Cardiac septal defects congenital,Cardiac and vascular disorders congenital,Cong,N
97,3,Pulmonary valve stenosis,Pulmonary valvular disorders,Cardiac valve disorders,Card,N
97,4,Ventricular septal defect,Cardiac septal defects congenital,Cardiac and vascular disorders congenital,Cong,N
98,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
99,1,Procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
100,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
100,2,Muscle haemorrhage,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
100,3,Shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
101,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
102,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
102,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
103,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
103,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
103,3,Headache,Headaches NEC,Headaches,Nerv,N
103,4,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
104,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
104,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
105,1,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
105,2,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
106,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
106,2,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
107,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
108,1,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
109,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
109,2,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
109,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
110,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
111,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
112,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
112,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
112,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
112,4,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
113,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
113,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
113,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
113,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
114,1,Congenital hand malformation,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
115,1,Congenital hand malformation,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
116,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
117,1,Haemorrhagic diathesis,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
118,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
118,2,Papule,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
119,1,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
120,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
120,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
121,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
121,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
121,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
122,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
123,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
124,1,Joint dislocation,Fractures and dislocations NEC,Bone and joint injuries,Inj&P,N
124,2,Post procedural haematoma,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
125,1,Post procedural haematoma,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
126,1,Post procedural haematoma,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
127,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
127,2,Post procedural haematoma,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
128,1,Post procedural haematoma,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
129,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
130,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
130,2,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
131,1,Post procedural haematoma,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
132,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
132,2,Laryngeal oedema,"Laryngeal spasm, oedema and obstruction",Upper respiratory tract disorders (excl infections),Resp,N
132,3,Papilloedema,Optic disc abnormalities NEC,"Ocular structural change, deposit and degeneration NEC",Eye,N
132,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
133,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
133,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
134,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
135,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
136,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
136,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
137,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
137,2,Uterine haemorrhage,Uterine disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
138,1,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
139,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
139,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
140,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
141,1,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
142,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
143,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
144,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
144,2,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
144,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
145,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
145,2,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
145,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
146,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
147,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
148,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
148,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
149,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
150,1,Myasthenia gravis,Neuromuscular junction dysfunction,Neuromuscular disorders,Nerv,N
151,1,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
151,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
152,1,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
153,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
154,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
155,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
156,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
157,1,Intra-abdominal haematoma,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
158,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
159,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
160,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
161,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
162,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
162,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
162,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
163,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
163,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
164,1,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
165,1,Intra-abdominal haematoma,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
166,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
166,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
167,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
167,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
167,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
168,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
169,1,Eye swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
169,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
170,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
171,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
171,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
172,1,Compartment syndrome,Myopathies,Muscle disorders,Musc,N
173,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
173,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
173,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
173,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
174,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
175,1,Extradural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
175,2,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
176,1,Retroperitoneal haematoma,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,Y
177,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
177,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
178,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
178,2,Intra-abdominal haematoma,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
179,1,Intra-abdominal haematoma,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
180,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
180,2,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
180,3,Radiculitis brachial,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
181,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
181,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
181,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
182,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
183,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
183,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
183,3,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
183,4,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
184,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
184,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
185,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
186,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
187,1,Face oedema,Oedema NEC,General system disorders NEC,Genrl,N
188,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
189,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
189,2,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
189,3,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
189,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
190,1,Apgar score low,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
190,2,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,Y
191,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
192,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
193,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
193,2,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
193,3,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
194,1,Post procedural haematoma,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
195,1,Post procedural haematoma,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
196,1,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
196,2,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
197,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
197,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
197,3,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
197,4,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
198,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
198,2,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
198,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
199,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
200,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
200,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
200,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
200,4,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
200,5,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
201,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
202,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
203,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
203,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
204,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
205,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
205,2,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
205,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
206,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
207,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
208,1,Photophobia,Ocular sensation disorders,Ocular sensory symptoms NEC,Eye,N
208,2,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
209,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
210,1,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
211,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
212,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
213,1,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
213,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
214,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
214,2,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
214,3,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
215,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
215,2,Injection site induration,Injection site reactions,Administration site reactions,Genrl,N
215,3,Injection site pustule,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
216,1,Foetal hypokinesia,Foetal complications NEC,Foetal complications,Preg,N
217,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
218,1,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
219,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
220,1,Cellulitis gangrenous,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
220,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
221,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
222,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
222,2,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
222,3,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
223,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
224,1,Anticoagulation drug level below therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
225,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
225,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
226,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
226,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
226,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
226,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
226,5,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
227,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
227,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
227,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
227,4,Morbid thoughts,Thinking disturbances,Disturbances in thinking and perception,Psych,N
227,5,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
228,1,Hip arthroplasty,Joint therapeutic procedures,Bone and joint therapeutic procedures,Surg,N
228,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
229,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
229,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
230,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
230,2,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
231,1,Abdominal wall haemorrhage,Abdominal wall conditions NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
231,2,Pelvic haemorrhage,Pelvis and broad ligament disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
231,3,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,Y
232,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
232,2,Vaginal mucosal blistering,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
233,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
234,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
235,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
235,2,Osteopenia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
235,3,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
236,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
237,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
238,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
238,2,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
238,3,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
238,4,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
238,5,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
238,6,Foetal malpresentation,Foetal position and presentation abnormalities,Foetal complications,Preg,N
238,7,Hemiplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
238,8,Hypocoagulable state,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
238,9,Hypotonia,Muscle tone abnormal,Neuromuscular disorders,Nerv,N
238,10,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
238,11,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
238,12,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
238,13,Premature rupture of membranes,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
239,1,Arachnoiditis,Central nervous system inflammatory disorders NEC,Central nervous system infections and inflammations,Nerv,N
239,2,Cauda equina syndrome,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
239,3,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
239,4,Nerve injury,Nerve injuries NEC,Injuries NEC,Inj&P,N
239,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
239,6,Spinal compression fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
239,7,Spinal cord injury,Spinal cord injuries NEC,Injuries NEC,Inj&P,N
240,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
241,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
242,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
243,1,Procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
244,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
245,1,Escherichia sepsis,Escherichia infections,Bacterial infectious disorders,Infec,N
245,2,Mouth haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
245,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
245,4,Urinary tract infection bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
246,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
247,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
247,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
247,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
248,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
249,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
250,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
250,2,Haemothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
251,1,Headache,Headaches NEC,Headaches,Nerv,N
251,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
252,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
253,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
254,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
254,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
254,3,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
255,1,Factor V deficiency,Coagulation disorders congenital,Blood and lymphatic system disorders congenital,Cong,N
255,2,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
256,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
256,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
256,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
257,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
258,1,Chest X-ray abnormal,Respiratory tract and thoracic imaging procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
258,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
258,3,Drug abuse,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
258,4,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
258,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
258,6,Fibrin D dimer increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
258,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
258,8,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
258,9,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
258,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
258,11,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
259,1,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
259,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
260,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
260,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
261,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
262,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
263,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
264,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
265,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,Y
266,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,Y
267,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
267,2,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
267,3,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,Y
268,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
268,2,Headache,Headaches NEC,Headaches,Nerv,N
268,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
268,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
268,5,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
269,1,Cardiac ventricular thrombosis,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
269,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
269,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
270,1,Application site pain,Application site reactions,Administration site reactions,Genrl,N
271,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
272,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
272,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
273,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
273,2,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
273,3,Electrocardiogram change,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
273,4,Haemolysis,Haemolyses NEC,Haemolyses and related conditions,Blood,N
273,5,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
274,1,Aggression,Behaviour and socialisation disturbances,Personality disorders and disturbances in behaviour,Psych,N
274,2,Anger,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
274,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
274,4,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
275,1,Antiphospholipid antibodies,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
275,2,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
276,1,Anticoagulation drug level above therapeutic,Therapeutic drug monitoring analyses,Toxicology and therapeutic drug monitoring,Inv,N
276,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
276,3,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
276,4,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
276,5,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
276,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
276,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
276,8,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
276,9,Subcutaneous haematoma,Skin injuries NEC,Injuries NEC,Inj&P,N
276,10,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
277,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
278,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
278,2,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
278,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
279,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
279,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
279,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
279,4,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
279,5,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
280,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
281,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
282,1,Injection site hypersensitivity,Injection site reactions,Administration site reactions,Genrl,N
283,1,Haemangioma of skin,Skin neoplasms benign,Cutaneous neoplasms benign,Neopl,N
284,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
284,2,Coagulation test abnormal,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
285,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
286,1,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
287,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
288,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
288,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
288,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
289,1,Laboratory test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
290,1,Anti factor X antibody positive,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
291,1,Coagulation factor X level increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
292,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
292,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
293,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
293,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
294,1,Headache,Headaches NEC,Headaches,Nerv,N
295,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
296,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
297,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
297,2,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
298,1,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
299,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
299,2,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
299,3,Mobility decreased,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
300,1,Dizziness exertional,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
300,2,Headache,Headaches NEC,Headaches,Nerv,N
301,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
302,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
303,1,Abdominal wall haematoma,Abdominal wall conditions NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
304,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
304,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
305,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
306,1,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
306,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
307,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
308,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
309,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
309,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
309,3,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
309,4,Injection site warmth,Injection site reactions,Administration site reactions,Genrl,N
310,1,Platelet count abnormal,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
311,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
311,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
312,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
313,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
314,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
314,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
315,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
315,2,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
315,3,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
315,4,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
315,5,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
315,6,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
315,7,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
315,8,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
315,9,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
315,10,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
316,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
316,2,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
316,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
316,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
317,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
317,2,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
317,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
318,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
318,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
318,3,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
318,4,Feeding disorder,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
318,5,Oral disorder,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
318,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
318,7,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
318,8,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
318,9,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
318,10,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
319,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
319,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
320,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
321,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
321,2,Coagulation factor increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
321,3,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
321,4,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
322,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
322,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
322,3,Dissociation,Dissociative states,Dissociative disorders,Psych,N
322,4,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
322,5,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
322,6,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
322,7,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
323,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
324,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
325,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
326,1,Osteoporotic fracture,Fractures NEC,Fractures,Musc,N
327,1,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
327,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
328,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
329,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
330,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
331,1,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
331,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
332,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
332,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
332,3,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
332,4,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
332,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
332,6,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
332,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
333,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
333,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
334,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
334,2,Femoral artery embolism,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
335,1,Femoral artery embolism,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
336,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
336,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
336,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
337,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
338,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
339,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
340,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
340,2,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
340,3,Incorrect product administration duration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
340,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
340,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
340,6,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
340,7,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
341,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
341,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
342,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
342,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
343,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
343,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
344,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
344,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
345,1,Embolism venous,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
345,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
346,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
347,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
347,2,Infrequent bowel movements,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
347,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
348,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
348,2,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
348,3,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
348,4,Soft tissue injury,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
349,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
349,2,Haematoma muscle,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
350,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
350,2,Blood calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
350,3,Blood thyroid stimulating hormone increased,Pituitary analyses anterior,Endocrine investigations (incl sex hormones),Inv,N
350,4,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
350,5,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
350,6,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
350,7,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
350,8,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
350,9,Monocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
350,10,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
350,11,Serum ferritin increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
350,12,Thyroxine free decreased,Thyroid analyses,Endocrine investigations (incl sex hormones),Inv,N
350,13,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
351,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
351,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
351,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
351,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
352,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
352,2,Pre-eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
352,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
352,4,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
353,1,Gastric haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
353,2,Peptic ulcer perforation,Peptic ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
354,1,Headache,Headaches NEC,Headaches,Nerv,N
355,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
355,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
355,3,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
356,1,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
357,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
357,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
357,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
357,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
357,5,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
357,6,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
358,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
358,2,Transplant failure,Transplantation complications,Procedural related injuries and complications NEC,Inj&P,N
359,1,Inflammation,Inflammations,General system disorders NEC,Genrl,N
359,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
360,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
361,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
362,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
362,2,Formication,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
362,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
362,4,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
362,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
362,6,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
362,7,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
363,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
363,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
363,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
364,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
364,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
365,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
365,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
365,3,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
366,1,Cauda equina syndrome,Lumbar spinal cord and nerve root disorders,Spinal cord and nerve root disorders,Nerv,N
366,2,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
366,3,Spinal subdural haematoma,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
367,1,Acute abdomen,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
367,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
367,3,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
367,4,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
367,5,Duodenal perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
367,6,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
367,7,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
367,8,Neutrophilia,Leukocytoses NEC,White blood cell disorders,Blood,N
367,9,Peritonitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
367,10,Procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,Y
367,11,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
367,12,Thrombocytosis,Thrombocytoses,Platelet disorders,Blood,N
368,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
369,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
369,2,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
369,3,Drooling,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
369,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
369,5,Dysarthria,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
369,6,Facial paresis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
369,7,Headache,Headaches NEC,Headaches,Nerv,N
369,8,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
369,9,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
369,10,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
370,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
370,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
370,3,Metabolic acidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
370,4,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,Y
371,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
371,2,Hair colour changes,Pilar disorders NEC,Skin appendage conditions,Skin,N
371,3,Hair growth abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
371,4,Hair texture abnormal,Pilar disorders NEC,Skin appendage conditions,Skin,N
372,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
372,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
372,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
373,1,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
373,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,Y
374,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,Y
375,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
375,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
375,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
375,4,Intra-abdominal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
375,5,Pelvic haemorrhage,Pelvis and broad ligament disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
376,1,Abnormal behaviour,Abnormal behaviour NEC,Psychiatric and behavioural symptoms NEC,Psych,N
376,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
376,3,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
376,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
377,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
378,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
379,1,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
380,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
381,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
381,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
382,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
382,2,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
383,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
384,1,Coronary artery thrombosis,Coronary artery disorders NEC,Coronary artery disorders,Card,N
384,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
384,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
385,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
386,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
386,2,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
387,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
388,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
388,2,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
389,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
390,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
390,2,Metastatic gastric cancer,Gastric neoplasms malignant,Gastrointestinal neoplasms malignant and unspecified,Neopl,Y
390,3,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
391,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
391,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
391,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
391,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
391,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
392,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
392,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
392,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
392,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
392,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
393,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,Y
394,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
395,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
396,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
396,2,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
397,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
397,2,Compartment syndrome,Myopathies,Muscle disorders,Musc,N
397,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
397,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
397,5,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
397,6,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
397,7,Muscle oedema,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
397,8,Muscle tightness,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
397,9,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
397,10,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
397,11,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
397,12,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
398,1,Compartment syndrome,Myopathies,Muscle disorders,Musc,N
398,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
398,3,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
399,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
400,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
400,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
400,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
400,4,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
401,1,Compartment syndrome,Myopathies,Muscle disorders,Musc,N
401,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
401,3,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
401,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
401,5,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
401,6,Muscle oedema,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
401,7,Muscle tightness,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
401,8,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
401,9,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
401,10,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
401,11,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
401,12,Skin disorder,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
402,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
402,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
403,1,Postpartum haemorrhage,Postpartum complications NEC,Postpartum and puerperal disorders,Preg,Y
404,1,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
405,1,Compartment syndrome,Myopathies,Muscle disorders,Musc,N
405,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
405,3,Procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
406,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
406,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
406,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
406,4,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
407,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
407,2,Tooth abscess,Dental and oral soft tissue infections,Infections - pathogen unspecified,Infec,N
408,1,Extradural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
408,2,International normalised ratio decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
408,3,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
409,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
410,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
410,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
410,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
411,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
411,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
411,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
411,4,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
411,5,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
411,6,Vasodilatation,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
412,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
412,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
412,3,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
412,4,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
412,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
412,6,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
412,7,Headache,Headaches NEC,Headaches,Nerv,N
412,8,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
412,9,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
412,10,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
412,11,Prosthetic cardiac valve thrombosis,Cardiac complications associated with device,Complications associated with device,Genrl,N
413,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
413,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
414,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
415,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
415,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
415,3,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
415,4,Death,Death and sudden death,Fatal outcomes,Genrl,Y
415,5,Echocardiogram abnormal,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
415,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
415,7,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
415,8,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
415,9,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
415,10,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
416,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
417,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
417,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
417,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
418,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
419,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
419,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
419,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
419,4,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
419,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
419,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
420,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
421,1,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
421,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
422,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
422,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
422,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
423,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
424,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
425,1,Haemorrhagic transformation stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
426,1,Cholangitis sclerosing,Bile duct infections and inflammations,Bile duct disorders,Hepat,N
426,2,Colitis ulcerative,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
426,3,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
427,1,Contraindication to medical treatment,Social issues NEC,Lifestyle issues,SocCi,N
427,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
427,3,Mouth haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
428,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
428,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
428,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
428,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
428,5,Muscle haemorrhage,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
428,6,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
429,1,International normalised ratio abnormal,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
429,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
430,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
430,2,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
431,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
432,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
433,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
433,2,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
433,3,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
433,4,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
434,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
434,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
434,3,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
434,4,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
434,5,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
434,6,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
434,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
434,8,Tooth loss,Tooth missing,Dental and gingival conditions,Gastr,N
435,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
436,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
436,2,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
437,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
437,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
437,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
437,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
438,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
439,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
439,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
439,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
439,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
440,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
440,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
441,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
442,1,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
442,2,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
443,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
444,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
444,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
444,3,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
445,1,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
445,2,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
446,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
447,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
447,2,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
448,1,Polyp,Mucosal findings abnormal,General system disorders NEC,Genrl,N
449,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
450,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
451,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
452,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
452,2,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
453,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
453,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
454,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
455,1,Headache,Headaches NEC,Headaches,Nerv,N
455,2,Migraine,Migraine headaches,Headaches,Nerv,N
455,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
455,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
456,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
457,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
457,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
457,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
458,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
459,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
460,1,Abdominal compartment syndrome,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
460,2,Abdominal compartment syndrome,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
460,3,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
460,4,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
460,5,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,Y
460,6,Shock haemorrhagic,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
461,1,Blood blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
462,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
463,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
463,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
464,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
465,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
465,2,Hyperpyrexia,Febrile disorders,Body temperature conditions,Genrl,N
465,3,Muscle fatigue,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
466,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
467,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
467,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
467,3,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
467,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
467,5,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
467,6,Hydrocephalus,Hydrocephalic conditions,Increased intracranial pressure and hydrocephalus,Nerv,N
467,7,Intraventricular haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
467,8,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
467,9,Prothrombin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
468,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
469,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
469,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
470,1,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
471,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
471,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
471,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
471,4,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
471,5,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
471,6,Troponin increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
472,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
472,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
472,3,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
473,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
473,2,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
473,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
474,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
474,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
474,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
474,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
474,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
475,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
475,2,Contraindication to medical treatment,Social issues NEC,Lifestyle issues,SocCi,N
475,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
476,1,Eczema eyelids,"Lid, lash and lacrimal infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
476,2,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
476,3,Eye pruritus,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
477,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
478,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
478,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
478,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
478,4,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
478,5,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
478,6,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
479,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
479,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
479,3,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
479,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
480,1,Cardiac flutter,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
480,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
480,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
480,4,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
481,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
481,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
482,1,Bone density decreased,Musculoskeletal and soft tissue imaging procedures,Musculoskeletal and soft tissue investigations (excl enzyme tests),Inv,N
482,2,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
483,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
484,1,Anal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
484,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
485,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
485,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
486,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
486,2,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
486,3,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
486,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
486,5,Pupil fixed,Pupil disorders,Ocular neuromuscular disorders,Eye,N
487,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
488,1,Renal tubular acidosis,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
489,1,Migraine,Migraine headaches,Headaches,Nerv,N
490,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
490,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
490,3,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
490,4,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
490,5,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
490,6,Headache,Headaches NEC,Headaches,Nerv,N
490,7,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
490,8,Lipodystrophy acquired,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
491,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
491,2,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
492,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
493,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
494,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
494,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
494,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
494,4,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
495,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
495,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
496,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
496,2,Calciphylaxis,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
496,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
496,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
497,1,Hyperaldosteronism,Adrenal cortical hyperfunctions,Adrenal gland disorders,Endo,N
497,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
497,3,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
498,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
498,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
499,1,Blood potassium increased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
499,2,Renal cell carcinoma,Renal neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
500,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
501,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
502,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
502,2,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
503,1,Epilepsy,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
503,2,Joint stiffness,Joint related signs and symptoms,Joint disorders,Musc,N
503,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
503,4,Sensory disturbance,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
504,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
504,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
505,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
505,2,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
505,3,Wound haemorrhage,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
506,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
506,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
507,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
508,1,Haemorrhage in pregnancy,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
508,2,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
508,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
508,4,Oligohydramnios,Amniotic fluid and cavity disorders of pregnancy NEC,"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
508,5,Oligohydramnios,Amniotic fluid and cavity disorders of pregnancy NEC,"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
508,6,Placental insufficiency,Placental abnormalities (excl neoplasms),"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
508,7,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
508,8,Preterm premature rupture of membranes,Maternal complications of pregnancy NEC,Maternal complications of pregnancy,Preg,N
508,9,Streptococcal bacteraemia,Streptococcal infections,Bacterial infectious disorders,Infec,N
508,10,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
509,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
509,2,Musculoskeletal pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
509,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
510,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
510,2,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
510,3,Oesophageal ulcer,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
510,4,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
511,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
512,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
513,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
513,2,Duodenal ulcer haemorrhage,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
513,3,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
514,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
514,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
514,3,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
514,4,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
514,5,Oesophageal ulcer,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
514,6,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
515,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
515,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
515,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
516,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
516,2,Cardiac tamponade,Pericardial disorders NEC,Pericardial disorders,Card,Y
516,3,Pericardial effusion,Pericardial disorders NEC,Pericardial disorders,Card,N
517,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
518,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
519,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
520,1,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
520,2,Product physical issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
521,1,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
522,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
523,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
523,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
523,3,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
523,4,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
524,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
524,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
524,3,Treatment noncompliance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
525,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
525,2,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
525,3,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
526,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
526,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
527,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
527,2,Extrasystoles,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
527,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
527,4,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
527,5,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
528,1,Amniorrhoea,Amniotic fluid and cavity disorders of pregnancy NEC,"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
528,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
528,3,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
528,4,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
529,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
530,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
530,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
530,3,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
530,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
531,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
532,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
532,2,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
533,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
534,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
534,2,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
535,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
535,2,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
536,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
536,2,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
537,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
538,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
539,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
540,1,Femoral nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
540,2,Haematoma muscle,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
541,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
542,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
543,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
544,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
544,2,Migraine,Migraine headaches,Headaches,Nerv,N
544,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
544,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
545,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
545,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
546,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
546,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
546,3,Haemothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
546,4,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
546,5,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
547,1,Cytogenetic abnormality,Chromosomal abnormalities NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
547,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
548,1,Cytogenetic abnormality,Chromosomal abnormalities NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
548,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
549,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
549,2,Fallopian tube disorder,Ovarian and fallopian tube disorders NEC,Ovarian and fallopian tube disorders,Repro,N
549,3,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
549,4,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
549,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
549,6,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
549,7,Prolonged labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
549,8,Surgical failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
549,9,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
550,1,Congenital anomaly,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
550,2,Foetal chromosome abnormality,Chromosomal abnormalities NEC,"Chromosomal abnormalities, gene alterations and gene variants",Cong,N
550,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
551,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
552,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
553,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
553,2,Migraine,Migraine headaches,Headaches,Nerv,N
553,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
553,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
553,5,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
553,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
554,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
555,1,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
556,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
557,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
557,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
557,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
558,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
558,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
559,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
559,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
559,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
559,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
559,5,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
560,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
561,1,Ascites,Peritoneal and retroperitoneal disorders,Peritoneal and retroperitoneal conditions,Gastr,N
561,2,Neoplasm malignant,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
562,1,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
562,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
562,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
562,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
562,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
562,6,Headache,Headaches NEC,Headaches,Nerv,N
562,7,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
562,8,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
562,9,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
562,10,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
562,11,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
563,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
564,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
564,2,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,Y
564,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
564,4,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
564,5,Hypoxic-ischaemic encephalopathy,Encephalopathies NEC,Encephalopathies,Nerv,N
564,6,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
564,7,Pulseless electrical activity,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
564,8,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
564,9,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
565,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
565,2,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
566,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
566,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
567,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
567,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
567,3,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
568,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
568,2,Headache,Headaches NEC,Headaches,Nerv,N
568,3,Hepatic pain,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
568,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
568,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
569,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
569,2,Transfusion,Blood and blood product treatment,Haematological and lymphoid tissue therapeutic procedures,Surg,N
570,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
570,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
571,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
572,1,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
573,1,Bowel movement irregularity,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
573,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
573,3,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
573,4,Incoherent,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
573,5,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
573,6,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
574,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
574,2,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
575,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
575,2,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
575,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
575,4,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
575,5,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,Y
575,6,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
575,7,Infarction,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
575,8,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
575,9,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
575,10,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
576,1,Administration site rash,Administration site reactions NEC,Administration site reactions,Genrl,N
577,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
577,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
577,3,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
577,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,Y
578,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
578,2,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
579,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
580,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
580,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
581,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
582,1,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
583,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
584,1,Nephrosclerosis,Nephropathies and tubular disorders NEC,Nephropathies,Renal,N
584,2,Renal haemorrhage,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,Y
584,3,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
585,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
586,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
587,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
587,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
587,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
588,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
588,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
589,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
589,2,Headache,Headaches NEC,Headaches,Nerv,N
589,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
589,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
590,1,Cytomegalovirus colitis,Cytomegaloviral infections,Viral infectious disorders,Infec,Y
590,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
590,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
590,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
591,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
592,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
593,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
593,2,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
593,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
594,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
594,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
595,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
595,2,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
596,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
596,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
596,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
596,4,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
597,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
597,2,Consciousness fluctuating,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
598,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
598,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
598,3,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
598,4,Potentiating drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
598,5,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
599,1,Acute generalised exanthematous pustulosis,Pustular conditions,Epidermal and dermal conditions,Skin,N
599,2,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
600,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
600,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
600,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
601,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
601,2,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
601,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
602,1,Injection site discolouration,Injection site reactions,Administration site reactions,Genrl,N
602,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
602,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
603,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
604,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
605,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
605,2,Spinal disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
605,3,Weight gain poor,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
606,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
607,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
608,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
608,2,Breast cancer,Breast and nipple neoplasms malignant,Breast neoplasms malignant and unspecified (incl nipple),Neopl,N
609,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
609,2,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
610,1,Migraine,Migraine headaches,Headaches,Nerv,N
611,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
612,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
613,1,Abdominal wall haematoma,Abdominal wall conditions NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
613,2,Hypovolaemic shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,Y
614,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
615,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
615,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
615,3,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
616,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
616,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
616,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
616,4,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
617,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
617,2,Injection site discolouration,Injection site reactions,Administration site reactions,Genrl,N
617,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
617,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
617,5,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
618,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
619,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
620,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
621,1,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
622,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
623,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
623,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
624,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
624,2,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
625,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
626,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
627,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
628,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
628,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
628,3,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
629,1,Moaning,General signs and symptoms NEC,General system disorders NEC,Genrl,N
629,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
629,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
630,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
630,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
631,1,Moaning,General signs and symptoms NEC,General system disorders NEC,Genrl,N
631,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
631,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
632,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
632,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
632,3,Sensitive skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
632,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
633,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
634,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
635,1,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
636,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
637,1,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
637,2,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
638,1,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
639,1,Diplopia,Visual disorders NEC,Vision disorders,Eye,N
639,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
640,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
641,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
642,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
642,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
642,3,Intracranial haematoma,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
643,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
643,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
643,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
643,4,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
643,5,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
644,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
644,2,Mesenteric vein thrombosis,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
644,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
645,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
645,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
645,3,Stoma site haemorrhage,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
646,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
647,1,Renal haemorrhage,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
648,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
648,2,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
649,1,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
650,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
650,2,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
651,1,Bundle branch block right,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
651,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
651,3,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
651,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
651,5,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
651,6,Nephrotic syndrome,Glomerulonephritis and nephrotic syndrome,Nephropathies,Renal,N
651,7,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
651,8,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
651,9,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
651,10,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
651,11,QRS axis abnormal,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
651,12,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
651,13,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
651,14,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
652,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
652,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
652,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
652,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
653,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
654,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,Y
654,2,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
655,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
655,2,Traumatic haematoma,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
656,1,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
657,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
658,1,Micturition urgency,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
658,2,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
659,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
659,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
660,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
660,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
661,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
661,2,Dural arteriovenous fistula,Central nervous system vascular disorders NEC,Central nervous system vascular disorders,Nerv,N
661,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
661,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
662,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
663,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
663,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
663,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
664,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
665,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,Y
665,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
666,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
666,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
667,1,Breast swelling,Breast signs and symptoms,Breast disorders,Repro,N
667,2,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
668,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
668,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
669,1,Hypovolaemic shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
669,2,Inappropriate schedule of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
669,3,Intra-abdominal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
670,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
671,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
671,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
672,1,Allergic reaction to excipient,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
672,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
672,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
672,4,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
673,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
673,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
674,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
674,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
675,1,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
675,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
676,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
676,2,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
676,3,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
677,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
677,2,Headache,Headaches NEC,Headaches,Nerv,N
678,1,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
678,2,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
679,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
679,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
680,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
681,1,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
681,2,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
681,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
681,4,Ileus,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
681,5,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
682,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
682,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
683,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
684,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
685,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
686,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
686,2,Product physical consistency issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
686,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
687,1,Injection site haematoma,Injection site reactions,Administration site reactions,Genrl,N
687,2,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
688,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
688,2,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
688,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
689,1,Catheter site haemorrhage,Implant and catheter site reactions,Administration site reactions,Genrl,N
690,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
690,2,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
690,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
691,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
691,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
691,3,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
691,4,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
691,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
692,1,Discharge,General signs and symptoms NEC,General system disorders NEC,Genrl,N
692,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
692,3,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
692,4,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
692,5,Skin plaque,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
693,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
694,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
694,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
695,1,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
696,1,Contraindicated product prescribed,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
696,2,Endocarditis,Cardiac infections,Infections - pathogen unspecified,Infec,N
696,3,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
696,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
696,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
696,6,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
697,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
697,2,Spinal fracture,Spinal fractures and dislocations,Bone and joint injuries,Inj&P,N
698,1,Aspiration,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
698,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
698,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
698,4,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
699,1,Migraine,Migraine headaches,Headaches,Nerv,N
700,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
701,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
702,1,Administration site haematoma,Administration site reactions NEC,Administration site reactions,Genrl,N
703,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
703,2,Protein C decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
703,3,Protein S decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
703,4,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
704,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
704,2,Haemorrhage subcutaneous,Skin haemorrhages,Skin vascular abnormalities,Skin,N
704,3,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
704,4,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
705,1,Gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
705,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
705,3,Protein C decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
705,4,Protein S decreased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
705,5,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
705,6,Thrombocytosis,Thrombocytoses,Platelet disorders,Blood,N
706,1,Headache,Headaches NEC,Headaches,Nerv,N
707,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
707,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
708,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
708,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
708,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
709,1,Bleeding time abnormal,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
709,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
709,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
709,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
709,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
709,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
709,7,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
709,8,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
710,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
711,1,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
712,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
713,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
713,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
713,3,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
714,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
714,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
714,3,Eyelid ptosis,Eyelid movement disorders,Ocular neuromuscular disorders,Eye,N
715,1,Ecchymosis,Purpura and related conditions,Skin vascular abnormalities,Skin,N
716,1,Catheter site haemorrhage,Implant and catheter site reactions,Administration site reactions,Genrl,N
716,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
716,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
716,4,Headache,Headaches NEC,Headaches,Nerv,N
716,5,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
717,1,Femoral artery embolism,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
717,2,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
717,3,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
718,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
719,1,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
720,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
720,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
721,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
722,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
722,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
722,3,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
722,4,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
722,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
722,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
723,1,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
723,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
723,3,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
723,4,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
723,5,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
723,6,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
723,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
724,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
724,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
724,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
725,1,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
725,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
725,3,Contraindicated product prescribed,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
725,4,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
725,5,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
725,6,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
725,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
726,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
727,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
728,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
728,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
729,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
729,2,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
730,1,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
731,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
731,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
732,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
733,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
733,2,Fallopian tube disorder,Ovarian and fallopian tube disorders NEC,Ovarian and fallopian tube disorders,Repro,N
733,3,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
733,4,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
733,5,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
733,6,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
733,7,Prolonged labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
733,8,Surgical failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
733,9,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
734,1,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
734,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
735,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
735,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
735,3,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
735,4,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
735,5,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
736,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
736,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
737,1,Dilated cardiomyopathy,Cardiomyopathies,Myocardial disorders,Card,N
737,2,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
737,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
737,4,Placental disorder,Placental abnormalities (excl neoplasms),"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
737,5,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
738,1,Exposure via breast milk,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
738,2,Foetal distress syndrome,Foetal complications NEC,Foetal complications,Preg,N
738,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
738,4,Meconium stain,Amniotic fluid and cavity disorders of pregnancy NEC,"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
738,5,Small for dates baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
739,1,Hand dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
739,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
739,3,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
739,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
739,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
740,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
740,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
740,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
740,4,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
741,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
742,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
742,2,Haemorrhagic transformation stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
743,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
743,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
744,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
744,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
744,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
744,4,Superficial vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
745,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
745,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
745,3,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
745,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
746,1,Fat necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
747,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
747,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
747,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
747,4,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
748,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
749,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
749,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
749,3,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
750,1,Headache,Headaches NEC,Headaches,Nerv,N
750,2,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
751,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
751,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
752,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
752,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
752,3,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
753,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
753,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
753,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
753,4,Pneumonia aspiration,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
753,5,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
754,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
754,2,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
755,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
755,2,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
756,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
756,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
756,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
757,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
757,2,Rash vesicular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
758,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
759,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
760,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
761,1,Haemorrhagic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
762,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
763,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
764,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
764,2,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
764,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
764,4,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
765,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
766,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
767,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
767,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
768,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
768,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
768,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
769,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
770,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
771,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
772,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
773,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
774,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
775,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
776,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
776,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
776,3,Spinal cord ischaemia,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
777,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
778,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
779,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
780,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
781,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
781,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
781,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
782,1,Benign prostatic hyperplasia,Prostatic neoplasms and hypertrophy,Prostatic disorders (excl infections and inflammations),Repro,N
782,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
782,3,Micturition urgency,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
782,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
782,5,Prostatomegaly,"Prostatic signs, symptoms and disorders NEC",Prostatic disorders (excl infections and inflammations),Repro,N
782,6,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
783,1,Headache,Headaches NEC,Headaches,Nerv,N
784,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
785,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
786,1,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
786,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
786,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
787,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
787,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
787,3,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
787,4,Headache,Headaches NEC,Headaches,Nerv,N
787,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
787,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
787,7,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
787,8,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
787,9,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
787,10,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
788,1,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
789,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
790,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
791,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
792,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
793,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
793,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
793,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
794,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
795,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
796,1,Drug effective for unapproved indication,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
796,2,Renal atrophy,Renal structural abnormalities and trauma,Renal disorders (excl nephropathies),Renal,N
797,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
797,2,Eczema impetiginous,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
797,3,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
797,4,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
797,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
797,6,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
797,7,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
797,8,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
798,1,Administration site rash,Administration site reactions NEC,Administration site reactions,Genrl,N
799,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
800,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
800,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
801,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
801,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
801,3,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
801,4,Skin infection,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
801,5,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
801,6,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
801,7,Tongue discomfort,Tongue signs and symptoms,Tongue conditions,Gastr,N
802,1,Blood urine,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
802,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
802,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
802,4,Muscle rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
802,5,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
803,1,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
804,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
804,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
805,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
806,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
806,2,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
807,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
808,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
808,2,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
809,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
809,2,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
810,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
810,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
811,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
811,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
812,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
813,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
813,2,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
813,3,Product label issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
814,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
814,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
814,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
814,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
814,5,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
815,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
816,1,Atrial thrombosis,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
816,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
816,3,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
816,4,Jugular vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
817,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
818,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
818,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
818,3,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
818,4,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
818,5,Haemorrhagic transformation stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
818,6,Pelvic venous thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
819,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
819,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
819,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
819,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
819,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
820,1,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
820,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
820,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
820,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
821,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
821,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
821,3,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
821,4,Neutropenic infection,Infections NEC,Infections - pathogen unspecified,Infec,N
821,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
821,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
822,1,Neutropenic infection,Infections NEC,Infections - pathogen unspecified,Infec,N
822,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
823,1,Psychomotor hyperactivity,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
824,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
824,2,Foetal hypokinesia,Foetal complications NEC,Foetal complications,Preg,N
825,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
825,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
825,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
825,4,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
826,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
826,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
826,3,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
826,4,Electrocardiogram abnormal,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
826,5,Hypotensive crisis,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
826,6,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
826,7,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
827,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
828,1,Device issue,Device issues NEC,Device issues,Prod,N
828,2,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
828,3,Incorrect dose administered by device,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
828,4,Wrong technique in device usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
829,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
830,1,Headache,Headaches NEC,Headaches,Nerv,N
831,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
832,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
833,1,Aortic thrombosis,Aortic embolism and thrombosis,Embolism and thrombosis,Vasc,N
834,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
834,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
835,1,Lung consolidation,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
835,2,Pulmonary alveolar haemorrhage,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
836,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
836,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
836,3,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
836,4,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
837,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
838,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
838,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
838,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
839,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
840,1,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
840,2,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
840,3,Odynophagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
840,4,Pulmonary thrombosis,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
841,1,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
841,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
841,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
842,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
843,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
843,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
844,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
844,2,Headache,Headaches NEC,Headaches,Nerv,N
844,3,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
845,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
846,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
846,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
847,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
848,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
849,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
850,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
850,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
851,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
852,1,Anal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
853,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
854,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
855,1,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
856,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
857,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
858,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
859,1,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
860,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
861,1,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
862,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
863,1,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
864,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
865,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
865,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
865,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
865,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
866,1,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
867,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
867,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
867,3,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
867,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
867,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
867,6,Headache,Headaches NEC,Headaches,Nerv,N
867,7,Migraine,Migraine headaches,Headaches,Nerv,N
867,8,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
867,9,Rhinorrhoea,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
867,10,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
868,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
869,1,Headache,Headaches NEC,Headaches,Nerv,N
870,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
870,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
871,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
871,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
872,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
873,1,Headache,Headaches NEC,Headaches,Nerv,N
874,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
875,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
875,2,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
876,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
876,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
876,3,Periorbital swelling,Ocular disorders NEC,Eye disorders NEC,Eye,N
876,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
876,5,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
876,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
877,1,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
878,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
879,1,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
880,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
880,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
880,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
881,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
882,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
883,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
884,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
884,2,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
885,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
886,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
887,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
888,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
889,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
889,2,Febrile neutropenia,Neutropenias,White blood cell disorders,Blood,N
889,3,Neutropenic infection,Infections NEC,Infections - pathogen unspecified,Infec,N
889,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
890,1,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
891,1,Headache,Headaches NEC,Headaches,Nerv,N
891,2,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
892,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
892,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
893,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
893,2,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
893,3,Poor quality device used,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
894,1,Headache,Headaches NEC,Headaches,Nerv,N
895,1,Duodenitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
895,2,Gastritis erosive,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
895,3,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
895,4,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
896,1,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
897,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
897,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
897,3,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
897,4,Gastric ulcer haemorrhage,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
897,5,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
897,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
898,1,Thrombocytosis,Thrombocytoses,Platelet disorders,Blood,N
899,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
899,2,Hallucination,Hallucinations (excl sleep-related),Disturbances in thinking and perception,Psych,N
899,3,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
899,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
900,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
901,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
902,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
902,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
903,1,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
904,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
905,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
906,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
907,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
907,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
908,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
909,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
910,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
911,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
911,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
911,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
911,4,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
911,5,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
911,6,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
911,7,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
911,8,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
911,9,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
911,10,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
911,11,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
911,12,Myalgia,Muscle pains,Muscle disorders,Musc,N
911,13,Myalgia,Muscle pains,Muscle disorders,Musc,N
911,14,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
911,15,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
911,16,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
911,17,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
911,18,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
911,19,Spinal pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
912,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
913,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
913,2,Delirium,Deliria,Deliria (incl confusion),Psych,N
913,3,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
913,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
913,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
914,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
915,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
915,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
915,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
916,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
916,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
916,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
917,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
917,2,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
917,3,Emotional disorder,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
917,4,Expired product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
917,5,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
917,6,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
917,7,Product colour issue,Product physical issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
917,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
918,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
918,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
919,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
920,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
921,1,Bladder pain,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
921,2,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
922,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
923,1,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
924,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
925,1,Lip blister,Oral soft tissue disorders NEC,Oral soft tissue conditions,Gastr,N
925,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
926,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
927,1,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
928,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
929,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
930,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
931,1,Aplastic anaemia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
931,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
932,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
932,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
933,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
934,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
935,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
936,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
936,2,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
937,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
938,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
938,2,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
939,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
940,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
941,1,Diplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
942,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
943,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
944,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
945,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
946,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
947,1,Pneumocystis jirovecii pneumonia,Pneumocystis infections,Fungal infectious disorders,Infec,N
948,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
949,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
949,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
949,3,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
950,1,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
951,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
952,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
953,1,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
954,1,Platelet disorder,Platelet disorders NEC,Platelet disorders,Blood,N
955,1,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
955,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
956,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
957,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
957,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
958,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
959,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
960,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
960,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
961,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,Y
962,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
963,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
964,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
964,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
964,3,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
964,4,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
965,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
966,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
967,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
968,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
969,1,Device difficult to use,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
969,2,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
969,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
969,4,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
969,5,Poor quality device used,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
970,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
970,2,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
971,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
972,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
972,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
972,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
973,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
974,1,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
975,1,Device allergy,Allergic conditions NEC,Allergic conditions,Immun,N
976,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
977,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
978,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
979,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
979,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
980,1,Osteoporosis,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
981,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
982,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
983,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
984,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
985,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
986,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
987,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
988,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
989,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
989,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
989,3,Micturition urgency,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
989,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
990,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
990,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
990,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
990,4,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
991,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
991,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
992,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
993,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
994,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
995,1,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
995,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
996,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
996,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
996,3,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
997,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
998,1,White blood cell disorder,White blood cell abnormal findings NEC,White blood cell disorders,Blood,N
999,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1000,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1001,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1001,2,Maternal exposure timing unspecified,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1001,3,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
1002,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1003,1,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
1004,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1005,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1005,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1006,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1006,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1006,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1007,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1008,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1008,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1008,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1008,4,Extrasystoles,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1009,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1010,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1011,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1011,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1011,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1011,4,Vision blurred,Visual disorders NEC,Vision disorders,Eye,N
1012,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1012,2,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1013,1,Haemorrhagic transformation stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1014,1,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1014,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1015,1,Cutaneous vasculitis,Skin vasculitides,Skin vascular abnormalities,Skin,N
1015,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1016,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1017,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1018,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
1019,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1020,1,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1020,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1021,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1021,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1022,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1022,2,Product administration error,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1022,3,Product prescribing issue,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
